Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela A Bota

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Cancer Letters|December 20, 2024
N-acetylcysteine prevents cisplatin-induced cognitive impairments in an ovarian cancer rat modelNaomi Lomeli, Diana C Pearre, Javier Lepe, et al.
Cancer Research|May 25, 2017
3D Mathematical Modeling of Glioblastoma Suggests That Transdifferentiated Vascular Endothelial Cells Mediate Resistance to Current Standard-of-Care TherapyHuaming Yan, Mónica Romero-López, Lesly I Benitez, et al.
Cells|June 11, 2026
Simplified Procedure for Isolation and Culture of Neuronal Cells from Brains of Sickle Cell MiceYugal Goel, Mya A Arellano, Kendall O'Daniel, et al.
Cancer Research Communications|May 6, 2026
MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma ModelsJavier J Lepe, Jennifer D Tran, Naomi Lomeli, et al.
The Permanente Journal|March 19, 2015
Use of ERC-1671 Vaccine in a Patient with Recurrent Glioblastoma Multiforme after Progression during Bevacizumab Therapy: First Published ReportDaniela A Bota, Daniela Alexandru-Abrams, Chrystel Pretto, et al.
Plos One|October 22, 2024
Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastomaZahra Motahari, Javier J Lepe, Malia R Bautista, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastomaZahra Motahari, Javier J Lepe, Malia R Bautista, et al.
Vaccine|April 14, 2015
First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivityVirgil E J C Schijns, Chrystel Pretto, Laurent Devillers, et al.
Pharmacological Research|March 15, 2025
Dual targeting of the mitochondrial Lon peptidase 1 and the chymotrypsin-like proteasome activity as a potential therapeutic strategy in malignant astrocytoma modelsChristopher Douglas, Shashi Jain, Naomi Lomeli, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
WITHDRAWN: Dual targeting of mitochondrial Lon peptidase 1 and chymotrypsin-like protease by small molecule BT317, as potential therapeutics in malignant astrocytomasChristopher Douglas, Shashi Jain, Naomi Lomeli, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Cancer Letters|December 20, 2024
N-acetylcysteine prevents cisplatin-induced cognitive impairments in an ovarian cancer rat modelNaomi Lomeli, Diana C Pearre, Javier Lepe, et al.
Cancer Research|May 25, 2017
3D Mathematical Modeling of Glioblastoma Suggests That Transdifferentiated Vascular Endothelial Cells Mediate Resistance to Current Standard-of-Care TherapyHuaming Yan, Mónica Romero-López, Lesly I Benitez, et al.
Cells|June 11, 2026
Simplified Procedure for Isolation and Culture of Neuronal Cells from Brains of Sickle Cell MiceYugal Goel, Mya A Arellano, Kendall O'Daniel, et al.
Cancer Research Communications|May 6, 2026
MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma ModelsJavier J Lepe, Jennifer D Tran, Naomi Lomeli, et al.
The Permanente Journal|March 19, 2015
Use of ERC-1671 Vaccine in a Patient with Recurrent Glioblastoma Multiforme after Progression during Bevacizumab Therapy: First Published ReportDaniela A Bota, Daniela Alexandru-Abrams, Chrystel Pretto, et al.
Plos One|October 22, 2024
Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastomaZahra Motahari, Javier J Lepe, Malia R Bautista, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastomaZahra Motahari, Javier J Lepe, Malia R Bautista, et al.
Vaccine|April 14, 2015
First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivityVirgil E J C Schijns, Chrystel Pretto, Laurent Devillers, et al.
Pharmacological Research|March 15, 2025
Dual targeting of the mitochondrial Lon peptidase 1 and the chymotrypsin-like proteasome activity as a potential therapeutic strategy in malignant astrocytoma modelsChristopher Douglas, Shashi Jain, Naomi Lomeli, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
WITHDRAWN: Dual targeting of mitochondrial Lon peptidase 1 and chymotrypsin-like protease by small molecule BT317, as potential therapeutics in malignant astrocytomasChristopher Douglas, Shashi Jain, Naomi Lomeli, et al.
Pageof 9